FindTrial
Sign In

Genetics and its influence on physical characteristics in Indian Patients with Congenital Adrenal Hyperplasia due to 21-α hydroxylase deficiency.

Genotype phenotype correlation in Indian Patientswith Congenital Adrenal Hyperplasia due to 21-α hydroxylase deficiency.

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2019/04/018430
Enrollment
150
Registered
2019-04-05
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E250- Congenital adrenogenital disordersassociated with enzyme deficiency

Interventions

Intervention1: NIL: NIL Intervention2: NIL: NIL

Sponsors

None listed

Eligibility

Inclusion criteria

Inclusion criteria: Patients with clinically and biochemically diagnosed Congenital adrenal hyperplasia due to 21-α Hydroxylase deficiency.

Exclusion criteria

Exclusion criteria: Patientswith congenital adrenal hyperplasiahaving clinical and biochemical diagnosis of 11 Beta Hydroxylase deficiency or 3-Beta hydroxylase deficiency.

Design outcomes

Primary

MeasureTime frame
Genotype phenotype correlation in Indian Patients with Congenital Adrenal Hyperplasia due to 21-α hydroxylase deficiency.Timepoint: 1 year—

Secondary

MeasureTime frame
NoneTimepoint: Not applicable—

Countries

India

Contacts

Public ContactVirendra Patil

Assistant Professor

viru.patil33@gmail.com919860567491

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026